Kymera Therapeutics, Inc. (KYMR) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 3.4% on average (either way), rising 8 times and falling 4. EPS beat estimates 7 of 12 times; revenue 5 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | -1.32 | -1.26 | -4.8% | 1.4M | 3.3M | +3.4% |
| Q2 FY2026 | 2026-08-05 | -0.62 | -0.71 | +13.0% | 65.0M | 32.8M | +1.9% |
| Q1 FY2026 | 2026-04-30 | -0.71 | -0.89 | +20.2% | 34.4M | 8.3M | -1.0% |
| Q4 FY2025 | 2026-02-26 | -0.97 | -0.78 | -23.8% | 2.9M | 15.0M | +0.7% |
| Q3 FY2025 | 2025-11-04 | -0.90 | -0.71 | -26.8% | 2.8M | 14.5M | +0.3% |
| Q2 FY2025 | 2025-08-11 | -0.95 | -0.83 | -14.5% | 11.5M | 17.1M | -1.8% |
| Q1 FY2025 | 2025-05-09 | -0.82 | -0.92 | +10.9% | 22.1M | 12.4M | +4.5% |
| Q4 FY2024 | 2025-02-27 | -0.88 | -0.76 | -15.8% | 7.4M | 16.7M | -11.3% |